Search hospitals > Ontario > OTTAWA
University of Ottawa Heart Institute
Claim this profileOTTAWA, Ontario K1Y 4W7
Global Leader in Coronary Artery Disease
Global Leader in Heart Failure
Conducts research for Myocardial Ischemia
Conducts research for Atrial Fibrillation
Conducts research for Coronary Heart Disease
247 reported clinical trials
24 medical researchers
Summary
University of Ottawa Heart Institute is a medical facility located in OTTAWA, Ontario. This center is recognized for care of Coronary Artery Disease, Heart Failure, Myocardial Ischemia, Atrial Fibrillation, Coronary Heart Disease and other specialties. University of Ottawa Heart Institute is involved with conducting 247 clinical trials across 189 conditions. There are 24 research doctors associated with this hospital, such as Benjamin Hibbert, MD, Marc Ruel, MD, Vincent Chan, MD, and David H Birnie, MD.Area of expertise
1Coronary Artery Disease
Global Leader2Heart Failure
Global LeaderStage II
Stage III
Stage IV
Top PIs
Benjamin Hibbert, MDOttawa Heart Institute2 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Atrial Fibrillation
8 reported clinical trials
13 drugs studied
Marc Ruel, MDUniversity of Ottawa Heart Institute1 year of reported clinical research
Studies Coronary Artery Disease
Studies Heart Disease
6 reported clinical trials
11 drugs studied
Vincent Chan, MDUniversity Health Network4 years of reported clinical research
Studies Pain
Studies Hyperalgesia
4 reported clinical trials
6 drugs studied
David H Birnie, MDUniversity of Ottawa Heart Institute5 years of reported clinical research
Studies Atrial Fibrillation
Studies Sarcoidosis
5 reported clinical trials
10 drugs studied
Clinical Trials running at University of Ottawa Heart Institute
Atrial Fibrillation
Cardiovascular Disease
Mitral Valve Regurgitation
Coronary Artery Disease
Heart Failure
Ventricular Tachycardia
Coronary Heart Disease
Myocardial Ischemia
Ascending Aortic Aneurysm
Shock
Left Atrial Appendage Occlusion vs. NOAC
for Atrial Fibrillation
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.
Recruiting1 award N/A8 criteria
Watchman
for Atrial Fibrillation
This trial is testing if it's safe and effective to perform two heart procedures at the same time for patients with atrial fibrillation. One procedure fixes a leaky heart valve without surgery, and the other reduces stroke risk by closing a small part of the heart. This combined approach aims to reduce risks associated with multiple surgeries and anesthesia.
Recruiting1 award N/A6 criteria
Ablation
for Atrial Fibrillation
A multicentre, parallel group, two arm, single-blinded randomized clinical trial, assessing the efficacy of a patient-tailored catheter ablation (CA) strategy guided by atrial scar mapping in addition to pulmonary vein isolation (PVI) when compared to PVI alone in patients with persistent atrial fibrillation (AF).
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Ottawa Heart Institute?
University of Ottawa Heart Institute is a medical facility located in OTTAWA, Ontario. This center is recognized for care of Coronary Artery Disease, Heart Failure, Myocardial Ischemia, Atrial Fibrillation, Coronary Heart Disease and other specialties. University of Ottawa Heart Institute is involved with conducting 247 clinical trials across 189 conditions. There are 24 research doctors associated with this hospital, such as Benjamin Hibbert, MD, Marc Ruel, MD, Vincent Chan, MD, and David H Birnie, MD.